SSA
AGL icon

Schonfeld Strategic Advisors’s Agilon Health AGL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,594
Closed -$1.7M – 2166
2025
Q2 		$1.7M Buy
29,594
+9,472
+47% +$760K 0.01% 1067
2025
Q1 		$2.18M Buy
20,122
+16,582
+468% +$1.44M 0.01% 925
2024
Q4 		$168K Buy
3,540
+1,788
+102% +$108K ﹤0.01% 1787
2024
Q3 		$172K Buy
+1,752
New +$226K ﹤0.01% 1833
2024
Q2 		– Sell
-3,662
Closed -$558K – 2110
2024
Q1 		$558K Buy
+3,662
New +$609K ﹤0.01% 1442
2023
Q2 		– Sell
-1,649
Closed -$979K – 2092
2023
Q1 		$979K Sell
1,649
-1,504
-48% -$842K 0.01% 968
2022
Q4 		$1.27M Sell
3,153
-273
-8% -$128K 0.01% 1030
2022
Q3 		$2.01M Buy
+3,426
New +$2.05M 0.02% 858
2022
Q2 		– Sell
-800
Closed -$507K – 2489
2022
Q1 		$507K Buy
+800
New +$412K ﹤0.01% 1364
2021
Q3 		– Sell
-649
Closed -$659K – 2123
2021
Q2 		$659K Buy
+649
New +$569K 0.01% 1073

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Schonfeld Strategic Advisors's AGL Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 29,594 shares — an estimated $1.7M sold.

Schonfeld Strategic Advisors first reported a position in AGL in Q2 2021 and held it in 10 quarters. The position peaked at $2.18M in Q1 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 29,594 Agilon Health shares in Q3 2025, an estimated $1.7M.
  • Schonfeld Strategic Advisors first reported a position in Agilon Health in Q2 2021 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Agilon Health position peaked at $2.18M in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.